We are live on ! Find out more
HCMT

Highland Capital Management (Tennessee) Portfolio holdings

AUM $2.17B
1-Year Est. Return 54.74%
This Fund
S&P 500
This Quarter Est. Return
-2.88%
1 Year Est. Return
+54.74%
3 Year Est. Return
+141.9%
5 Year Est. Return
+171.7%
10 Year Est. Return
+576.48%
AUM
$1.67B
AUM Growth
-$96.4M
Cap. Flow
-$16M
Cap. Flow %
-0.96%
Top 10 Hldgs %
26.15%
Holding
355
New
17
Increased
148
Reduced
103
Closed
26

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$5.3M
2
WELL icon
Welltower
WELL
+$5.04M
3
O icon
Realty Income
O
+$4.96M
4
TMO icon
Thermo Fisher Scientific
TMO
+$4.85M
5
MET icon
MetLife
MET
+$4.62M

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$10.9M
2
COST icon
Costco
COST
+$7.1M
3
DIS icon
Walt Disney
DIS
+$6.72M
4
JLL icon
Jones Lang LaSalle
JLL
+$5.34M
5
WBA
Walgreens Boots Alliance
WBA
+$4.4M

Sector Composition

Rank Sector Weight
1 Technology 22.23%
2 Financials 12.8%
3 Healthcare 12.22%
4 Consumer Discretionary 9.3%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEAM icon
351
Atlassian
TEAM
$39.4B
– –
-5,585
Closed -$2.13M
UPST icon
352
Upstart Holdings
UPST
$2.83B
– –
-1,500
Closed -$227K
VRT icon
353
Vertiv
VRT
$111B
– –
-71,907
Closed -$1.8M
XLNX
354
DELISTED
Xilinx Inc
XLNX
– –
-2,237
Closed -$474K
RDS.B
355
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
– –
-28,198
Closed -$1.22M
11 12 13 14
15

Similar funds

ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Highland Capital Management (Tennessee)'s Q1 2022 Portfolio in Review

As of Q1 2022, Highland Capital Management (Tennessee) held 355 positions worth $1.67B, down 5.5% from $1.77B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Highland Capital Management (Tennessee)'s Q1 2022 filing shows 17 new, 148 increased, 103 reduced and 26 closed positions. Its largest new stake was Jazz Pharmaceuticals: 36,550 shares worth $5.69M. The largest sale was Freeport-McMoran, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Highland Capital Management (Tennessee)'s largest Q1 2022 buy was Jazz Pharmaceuticals: 36,550 shares worth $5.69M.
  • Highland Capital Management (Tennessee) added most to Thermo Fisher Scientific in Q1 2022, an estimated $4.85M increase.
  • Highland Capital Management (Tennessee)'s biggest Q1 2022 reduction was Freeport-McMoran, cutting an estimated $10.9M.
  • Highland Capital Management (Tennessee) fully exited Jones Lang LaSalle in Q1 2022, selling an estimated $5.34M.
  • Highland Capital Management (Tennessee)'s ten largest holdings make up 26% of its $1.67B portfolio in Q1 2022.
  • Highland Capital Management (Tennessee) opened 17 new positions and closed 26 in Q1 2022.
  • Highland Capital Management (Tennessee)'s portfolio value fell 5.5% quarter-over-quarter to $1.67B.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2022, filed 19 Apr 2022.